SlideShare une entreprise Scribd logo
1  sur  16
Télécharger pour lire hors ligne
EFFECT OF MACRO ECONOMIC FACTORS
ON PHARMACEUTICAL INDUSTRY
A PRESENTATION BY
MANIKANT JAISWAL
GROSS DOMESTIC PRODUCT (GDP)
 POSITIVE IMPACT: Increase in GDP leads to firms hiring
more and more workers and can afford increased
salaries . This leads to an increase in per capita income
which leads to increased spending by consumers. This
ensures that people can afford high quality healthcare
medicines/ services, giving a boost to pharma industry.
 NEGATIVE IMPACT: Decrease in GDP
 The additional funds would be required to strengthen
the primary healthcare infrastructure.
 Current expenditure 1.15 per cent of its GDP on
healthcare.
 Target to increase it to 2.5 per cent by 2025.
TRADE WAR
 US-China trade war , Indian exports grew by 11% to $19.2billion in
2018-2019 in North America and Europe.
 Increase in tariffs between US and China.
 China export increased by 2% in 2018-2019.
 China imports ingredients mostly from India.
 Earn foreign exchange.
 Boost economic activities.
GOVERNMENT INITIATIVES
 Government led initiatives such as JAN AUSHADI, Pharma Vision 2020
 Six pharmaceutical parks to be set up in Uttar Pradesh- investment commitments more than 5000-6000 cr.
 National Health Protection scheme-largest government funded health care program which will expect to
benefit 100million poor people
 Electronic platform to control the misuse due to availability of drugs and medicines
 Drug Controller General announced to start single window facility to provide consents, approvals & other
information. This move is aimed to give a push to MAKE IN INDIA initiative
GOVERNMENT REGULATIONS
 Pharmaceuticals manufacturers have to deal
with the issue of licensing which cause
substantial revenue loss.
 Licensing fees range from 5% to 25%
 Also recently government prices caps on 52
drugs. Post the price cap the revenue has
fallen by nearly 40%.
INVESTMENTS & RECENT DEVELOPMENTS
 Amendments in existing FDI policy in
the pharmaceutical sector – upto
100% allowed through automatic
route.
 Cumulative FDI inflows worth US
$15.98 billion attracted according to
data released by DIPP.
 These will impact the pharma industry
positively and will enhance the
efficiency of this sector.
INVESTMENTS & RECENT DEVELOPMENTS
 Between July- sept 2018, Indian
pharma sector saw 39 PE investment
deals worth US $217 million
 Investment( as % of sales) in research
and development by Indian pharma
companies increased from 5.3% in
FY12 to 8.5% FY18.
 46 M&A deals worth US$1.47 billion.
RATE OF UNEMPLOYMENT
 The rate of unemployment in
economy has a major impact
on any industry operating in
market.
 It directly impacts the GDP of
nation and per capita income
of individuals.
 This affects the pharma
industry majorly.
INFLATION
 Lack of funds and buying power resulting from soaring
inflation and high cost of borrowing are likely to cause
hurdle in the growth of the Indian pharmaceutical sector
Is it the medicines? Is it the insurance
scheme? Is it data error?
TAXES
Impact Of GST
There are two things that have changed which are the
manufacturing price of many raw materials for API and
product moved from 5% vat Bracket to 12% GST bracket
and a lot of medicines salts/compounds have moved
from 5% to 12% GST bracket.
MONETARY
POLICY
FISCAL
POLICY
• Monetary policy is the macroeconomic policy laid down by the
central bank to achieve macroeconomic objectives like inflation
consumption and growth.
• Key monetary policy instruments are open market operations, CRR,
SLR, Repo and reverse repo rate.
• Fiscal policy is the macroeconomic policy which deals with the
taxation and expenditure decisions of the government.
• Some of the major instruments of fiscal policy are as follows: Budget,
Taxation, Public Expenditure, public revenue, Public Debt, and Fiscal
Deficit in the economy.
Effect of macro economic factors on Pharmaceutical Industry
• Intellectual property rights such as patents provide pharma companies exclusive rights to make drugs and prevent
others to manufacture, sell, and make these drugs for A period of 20 years.
• A progressive policies regarding the IPR have an positive impact on the pharmaceutical industry.
RESEARCH & DEVELOPMENT/ INNOVATION
 The R&D efficiencies of major research-based
pharmaceutical companies were in the range of USD
3.2–32.3 billion (2006–2014). [Journal of Translation
Medicine, 2016]
 The total worldwide R&D spend of pharmaceutical
and biotechnology companies increased from USD
108 billion (2006) to USD 141 billion (2015) whereas
Top five Indian pharma companies together spent
over Rs. 8000 crore on R&D spend in FY17.
[Bloomberg]
 Medicine spending in India is projected to grow 9-12
per cent over the next five years, leading India to
become one of the top 10 countries in terms of
medicine spending.
EXCHANGE RATE
 Rupee depreciation against the Dollar will result in
cash inflows for pharmaceutical companies that
derive a significant part of their revenues from the
US.
 Firms, which undertook forward contracts of
hedging their sales revenues so as to insulate
themselves from currency fluctuations, will not
benefit much from Rupee depreciation.
 Profitability of companies is also affected by loans
they owe in foreign currency. Higher Dollar
conversion rate invariably results in higher interest
and loan repayments.
Thank You!

Contenu connexe

Tendances

Porter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma IndustriesPorter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma IndustriesPradeep555
 
Indian pharmaceutical industry
Indian pharmaceutical industry Indian pharmaceutical industry
Indian pharmaceutical industry Kushal Shah
 
PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)
PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)
PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)Alister Lopes
 
Status of pharmaceutical industry in india
Status of pharmaceutical industry in indiaStatus of pharmaceutical industry in india
Status of pharmaceutical industry in indiaShadab Khan
 
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY” Dharmik Bhatt
 
Study On Pharmaceuticals Companies
Study On Pharmaceuticals CompaniesStudy On Pharmaceuticals Companies
Study On Pharmaceuticals CompaniesVarsha Chauhan
 
indian pharmaceutical industry
indian pharmaceutical industryindian pharmaceutical industry
indian pharmaceutical industryKushal Shah
 
Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50domsr
 
Pharmaceutical Industry Analysis
Pharmaceutical Industry AnalysisPharmaceutical Industry Analysis
Pharmaceutical Industry AnalysisVARUN KESAVAN
 
Marketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun PharmaceuticalsMarketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun PharmaceuticalsAman Dube
 
India pharmacy retail market report -2020 |India Pharmacy Retail Market
India pharmacy retail market report -2020 |India Pharmacy Retail MarketIndia pharmacy retail market report -2020 |India Pharmacy Retail Market
India pharmacy retail market report -2020 |India Pharmacy Retail MarketKen Research Pvt ltd.
 
Growth drivers in Indian Pharma Industry
Growth drivers in Indian Pharma Industry Growth drivers in Indian Pharma Industry
Growth drivers in Indian Pharma Industry pharmacampus
 
competitive analysis of Abbott company.
competitive analysis of Abbott company.competitive analysis of Abbott company.
competitive analysis of Abbott company.bilal hassan
 
Strategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryStrategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryEngr. Carlo Senica, MBA, CPSM
 
Porter’S Forces In Pharmaceutical ind
Porter’S Forces In Pharmaceutical indPorter’S Forces In Pharmaceutical ind
Porter’S Forces In Pharmaceutical indPersonal
 
FMCG industry analysis
FMCG industry analysisFMCG industry analysis
FMCG industry analysisRisha Bagchi
 

Tendances (20)

Porter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma IndustriesPorter’S Five Force Model In Pharma Industries
Porter’S Five Force Model In Pharma Industries
 
Indian pharmaceutical industry
Indian pharmaceutical industry Indian pharmaceutical industry
Indian pharmaceutical industry
 
PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)
PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)
PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)
 
Status of pharmaceutical industry in india
Status of pharmaceutical industry in indiaStatus of pharmaceutical industry in india
Status of pharmaceutical industry in india
 
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
 
Study On Pharmaceuticals Companies
Study On Pharmaceuticals CompaniesStudy On Pharmaceuticals Companies
Study On Pharmaceuticals Companies
 
indian pharmaceutical industry
indian pharmaceutical industryindian pharmaceutical industry
indian pharmaceutical industry
 
Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50
 
Pharmaceutical Industry Analysis
Pharmaceutical Industry AnalysisPharmaceutical Industry Analysis
Pharmaceutical Industry Analysis
 
Marketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun PharmaceuticalsMarketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun Pharmaceuticals
 
India pharmacy retail market report -2020 |India Pharmacy Retail Market
India pharmacy retail market report -2020 |India Pharmacy Retail MarketIndia pharmacy retail market report -2020 |India Pharmacy Retail Market
India pharmacy retail market report -2020 |India Pharmacy Retail Market
 
Growth drivers in Indian Pharma Industry
Growth drivers in Indian Pharma Industry Growth drivers in Indian Pharma Industry
Growth drivers in Indian Pharma Industry
 
Sun pharma
Sun pharmaSun pharma
Sun pharma
 
competitive analysis of Abbott company.
competitive analysis of Abbott company.competitive analysis of Abbott company.
competitive analysis of Abbott company.
 
Strategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryStrategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical Industry
 
Porter’S Forces In Pharmaceutical ind
Porter’S Forces In Pharmaceutical indPorter’S Forces In Pharmaceutical ind
Porter’S Forces In Pharmaceutical ind
 
Cipla Presentation
Cipla PresentationCipla Presentation
Cipla Presentation
 
Dr. Reddy's Lab - Business Model
Dr. Reddy's Lab - Business ModelDr. Reddy's Lab - Business Model
Dr. Reddy's Lab - Business Model
 
FMCG industry analysis
FMCG industry analysisFMCG industry analysis
FMCG industry analysis
 
Cipla
CiplaCipla
Cipla
 

Similaire à Effect of macro economic factors on Pharmaceutical Industry

India pharmaceutical sector
India pharmaceutical sectorIndia pharmaceutical sector
India pharmaceutical sectorRahul Singh
 
Pharmaceutial market research
Pharmaceutial market researchPharmaceutial market research
Pharmaceutial market researchHitesh Pal
 
Pharmaceuticals Industry - A brief overview
Pharmaceuticals Industry - A brief overviewPharmaceuticals Industry - A brief overview
Pharmaceuticals Industry - A brief overviewAneesh S.V.L.S
 
Pharmaceutical marketing in the 21st century
Pharmaceutical marketing in the 21st centuryPharmaceutical marketing in the 21st century
Pharmaceutical marketing in the 21st centuryRamdas Dolas
 
Industrial environment SWOT analysis
Industrial environment SWOT analysis Industrial environment SWOT analysis
Industrial environment SWOT analysis Prof. Nikhil Lohe
 
Introduction to indian pharma industries
Introduction to indian pharma industriesIntroduction to indian pharma industries
Introduction to indian pharma industriespharmacampus
 
Industry overview ipm
Industry overview ipmIndustry overview ipm
Industry overview ipmbrandsynapse
 
Analysis of booming pharmaceutical sector in india
Analysis of booming pharmaceutical sector in indiaAnalysis of booming pharmaceutical sector in india
Analysis of booming pharmaceutical sector in indiaAbhijeet Malhotra
 
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGES
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGESNEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGES
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGESganpat420
 
WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...
WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...
WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...Saurabh
 
Indian Pharmaceutical Market Overview 2013 by Nitesh Bhele
Indian Pharmaceutical Market Overview 2013 by Nitesh BheleIndian Pharmaceutical Market Overview 2013 by Nitesh Bhele
Indian Pharmaceutical Market Overview 2013 by Nitesh BheleNitesh Bhele
 

Similaire à Effect of macro economic factors on Pharmaceutical Industry (20)

India pharmaceutical sector
India pharmaceutical sectorIndia pharmaceutical sector
India pharmaceutical sector
 
BEACON.Dec 2013
BEACON.Dec 2013BEACON.Dec 2013
BEACON.Dec 2013
 
Pharmaceutial market research
Pharmaceutial market researchPharmaceutial market research
Pharmaceutial market research
 
Pharmaceuticals Industry - A brief overview
Pharmaceuticals Industry - A brief overviewPharmaceuticals Industry - A brief overview
Pharmaceuticals Industry - A brief overview
 
Vipul Patil P.Marketing Assignment
Vipul Patil P.Marketing AssignmentVipul Patil P.Marketing Assignment
Vipul Patil P.Marketing Assignment
 
Pharmaceutical marketing in the 21st century
Pharmaceutical marketing in the 21st centuryPharmaceutical marketing in the 21st century
Pharmaceutical marketing in the 21st century
 
Industrial environment SWOT analysis
Industrial environment SWOT analysis Industrial environment SWOT analysis
Industrial environment SWOT analysis
 
Introduction to indian pharma industries
Introduction to indian pharma industriesIntroduction to indian pharma industries
Introduction to indian pharma industries
 
Pharmaceuticals Sector Report - January 2018
Pharmaceuticals Sector Report - January 2018Pharmaceuticals Sector Report - January 2018
Pharmaceuticals Sector Report - January 2018
 
Industry overview ipm
Industry overview ipmIndustry overview ipm
Industry overview ipm
 
India : Pharmaceuticals Sector Report_August 2013
India : Pharmaceuticals Sector Report_August 2013India : Pharmaceuticals Sector Report_August 2013
India : Pharmaceuticals Sector Report_August 2013
 
Analysis of booming pharmaceutical sector in india
Analysis of booming pharmaceutical sector in indiaAnalysis of booming pharmaceutical sector in india
Analysis of booming pharmaceutical sector in india
 
Pharmaceuticals Sector Report March 2018
Pharmaceuticals Sector Report March 2018Pharmaceuticals Sector Report March 2018
Pharmaceuticals Sector Report March 2018
 
Pharmaceuticals Sector Report - September 2018
Pharmaceuticals Sector Report - September 2018Pharmaceuticals Sector Report - September 2018
Pharmaceuticals Sector Report - September 2018
 
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGES
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGESNEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGES
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGES
 
winter project
winter projectwinter project
winter project
 
Pharmaceuticals Sector Report - April 2018
Pharmaceuticals Sector Report - April 2018Pharmaceuticals Sector Report - April 2018
Pharmaceuticals Sector Report - April 2018
 
Pharmaceuticals Sector Report - February 2018
Pharmaceuticals Sector Report - February 2018Pharmaceuticals Sector Report - February 2018
Pharmaceuticals Sector Report - February 2018
 
WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...
WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...
WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...
 
Indian Pharmaceutical Market Overview 2013 by Nitesh Bhele
Indian Pharmaceutical Market Overview 2013 by Nitesh BheleIndian Pharmaceutical Market Overview 2013 by Nitesh Bhele
Indian Pharmaceutical Market Overview 2013 by Nitesh Bhele
 

Dernier

ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTESACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTESKumarJayaraman3
 
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdfAdnet Communications
 
MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.Arifa Saeed
 
CLUB DEAL -DECK INVESTOR
CLUB DEAL -DECK INVESTORCLUB DEAL -DECK INVESTOR
CLUB DEAL -DECK INVESTORhnaour
 
Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Guillaume Ⓥ Sarlat
 
Hungarys economy made by Robert Miklos
Hungarys economy   made by Robert MiklosHungarys economy   made by Robert Miklos
Hungarys economy made by Robert Miklosbeduinpower135
 
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdfLundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdfAdnet Communications
 
Mphasis - Schwab Newsletter PDF - Sample 8707
Mphasis - Schwab Newsletter PDF - Sample 8707Mphasis - Schwab Newsletter PDF - Sample 8707
Mphasis - Schwab Newsletter PDF - Sample 8707harshan90
 
Taipei, A Hidden Jewel in East Asia - PR Strategy for Tourism
Taipei, A Hidden Jewel in East Asia - PR Strategy for TourismTaipei, A Hidden Jewel in East Asia - PR Strategy for Tourism
Taipei, A Hidden Jewel in East Asia - PR Strategy for TourismBrian Lin
 
The Pension Regulator's "desputed numbers"
The Pension Regulator's "desputed numbers"The Pension Regulator's "desputed numbers"
The Pension Regulator's "desputed numbers"Henry Tapper
 
The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?Stephen Perrenod
 
Stock Market Brief Deck for March 19 2024.pdf
Stock Market Brief Deck for March 19 2024.pdfStock Market Brief Deck for March 19 2024.pdf
Stock Market Brief Deck for March 19 2024.pdfMichael Silva
 
CSR01P4 The foundations of CSR Part 4 Economic
CSR01P4 The foundations of CSR Part 4 EconomicCSR01P4 The foundations of CSR Part 4 Economic
CSR01P4 The foundations of CSR Part 4 EconomicMatthieu Bruckert
 
TriStar Gold- 03-13-2024 presentation pdf
TriStar Gold- 03-13-2024 presentation pdfTriStar Gold- 03-13-2024 presentation pdf
TriStar Gold- 03-13-2024 presentation pdfAdnet Communications
 
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGeckoRWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGeckoCoinGecko
 
Introduction to Entrepreneurship and Characteristics of an Entrepreneur
Introduction to Entrepreneurship and Characteristics of an EntrepreneurIntroduction to Entrepreneurship and Characteristics of an Entrepreneur
Introduction to Entrepreneurship and Characteristics of an Entrepreneurabcisahunter
 
Stock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdfStock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdfMichael Silva
 
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptxSlideshare - ONS Economic Forum Slidepack - 18 March 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptxOffice for National Statistics
 

Dernier (20)

ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTESACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
 
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
 
MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.
 
CLUB DEAL -DECK INVESTOR
CLUB DEAL -DECK INVESTORCLUB DEAL -DECK INVESTOR
CLUB DEAL -DECK INVESTOR
 
Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024
 
Hungarys economy made by Robert Miklos
Hungarys economy   made by Robert MiklosHungarys economy   made by Robert Miklos
Hungarys economy made by Robert Miklos
 
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdfLundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
 
Mphasis - Schwab Newsletter PDF - Sample 8707
Mphasis - Schwab Newsletter PDF - Sample 8707Mphasis - Schwab Newsletter PDF - Sample 8707
Mphasis - Schwab Newsletter PDF - Sample 8707
 
Taipei, A Hidden Jewel in East Asia - PR Strategy for Tourism
Taipei, A Hidden Jewel in East Asia - PR Strategy for TourismTaipei, A Hidden Jewel in East Asia - PR Strategy for Tourism
Taipei, A Hidden Jewel in East Asia - PR Strategy for Tourism
 
Monthly Economic Monitoring of Ukraine No.230, March 2024
Monthly Economic Monitoring of Ukraine No.230, March 2024Monthly Economic Monitoring of Ukraine No.230, March 2024
Monthly Economic Monitoring of Ukraine No.230, March 2024
 
New Monthly Enterprises Survey. Issue 21. (01.2024) Ukrainian Business in War...
New Monthly Enterprises Survey. Issue 21. (01.2024) Ukrainian Business in War...New Monthly Enterprises Survey. Issue 21. (01.2024) Ukrainian Business in War...
New Monthly Enterprises Survey. Issue 21. (01.2024) Ukrainian Business in War...
 
The Pension Regulator's "desputed numbers"
The Pension Regulator's "desputed numbers"The Pension Regulator's "desputed numbers"
The Pension Regulator's "desputed numbers"
 
The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?
 
Stock Market Brief Deck for March 19 2024.pdf
Stock Market Brief Deck for March 19 2024.pdfStock Market Brief Deck for March 19 2024.pdf
Stock Market Brief Deck for March 19 2024.pdf
 
CSR01P4 The foundations of CSR Part 4 Economic
CSR01P4 The foundations of CSR Part 4 EconomicCSR01P4 The foundations of CSR Part 4 Economic
CSR01P4 The foundations of CSR Part 4 Economic
 
TriStar Gold- 03-13-2024 presentation pdf
TriStar Gold- 03-13-2024 presentation pdfTriStar Gold- 03-13-2024 presentation pdf
TriStar Gold- 03-13-2024 presentation pdf
 
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGeckoRWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
 
Introduction to Entrepreneurship and Characteristics of an Entrepreneur
Introduction to Entrepreneurship and Characteristics of an EntrepreneurIntroduction to Entrepreneurship and Characteristics of an Entrepreneur
Introduction to Entrepreneurship and Characteristics of an Entrepreneur
 
Stock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdfStock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdf
 
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptxSlideshare - ONS Economic Forum Slidepack - 18 March 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptx
 

Effect of macro economic factors on Pharmaceutical Industry

  • 1. EFFECT OF MACRO ECONOMIC FACTORS ON PHARMACEUTICAL INDUSTRY A PRESENTATION BY MANIKANT JAISWAL
  • 2. GROSS DOMESTIC PRODUCT (GDP)  POSITIVE IMPACT: Increase in GDP leads to firms hiring more and more workers and can afford increased salaries . This leads to an increase in per capita income which leads to increased spending by consumers. This ensures that people can afford high quality healthcare medicines/ services, giving a boost to pharma industry.  NEGATIVE IMPACT: Decrease in GDP  The additional funds would be required to strengthen the primary healthcare infrastructure.  Current expenditure 1.15 per cent of its GDP on healthcare.  Target to increase it to 2.5 per cent by 2025.
  • 3. TRADE WAR  US-China trade war , Indian exports grew by 11% to $19.2billion in 2018-2019 in North America and Europe.  Increase in tariffs between US and China.  China export increased by 2% in 2018-2019.  China imports ingredients mostly from India.  Earn foreign exchange.  Boost economic activities.
  • 4. GOVERNMENT INITIATIVES  Government led initiatives such as JAN AUSHADI, Pharma Vision 2020  Six pharmaceutical parks to be set up in Uttar Pradesh- investment commitments more than 5000-6000 cr.  National Health Protection scheme-largest government funded health care program which will expect to benefit 100million poor people  Electronic platform to control the misuse due to availability of drugs and medicines  Drug Controller General announced to start single window facility to provide consents, approvals & other information. This move is aimed to give a push to MAKE IN INDIA initiative
  • 5. GOVERNMENT REGULATIONS  Pharmaceuticals manufacturers have to deal with the issue of licensing which cause substantial revenue loss.  Licensing fees range from 5% to 25%  Also recently government prices caps on 52 drugs. Post the price cap the revenue has fallen by nearly 40%.
  • 6. INVESTMENTS & RECENT DEVELOPMENTS  Amendments in existing FDI policy in the pharmaceutical sector – upto 100% allowed through automatic route.  Cumulative FDI inflows worth US $15.98 billion attracted according to data released by DIPP.  These will impact the pharma industry positively and will enhance the efficiency of this sector.
  • 7. INVESTMENTS & RECENT DEVELOPMENTS  Between July- sept 2018, Indian pharma sector saw 39 PE investment deals worth US $217 million  Investment( as % of sales) in research and development by Indian pharma companies increased from 5.3% in FY12 to 8.5% FY18.  46 M&A deals worth US$1.47 billion.
  • 8. RATE OF UNEMPLOYMENT  The rate of unemployment in economy has a major impact on any industry operating in market.  It directly impacts the GDP of nation and per capita income of individuals.  This affects the pharma industry majorly.
  • 9. INFLATION  Lack of funds and buying power resulting from soaring inflation and high cost of borrowing are likely to cause hurdle in the growth of the Indian pharmaceutical sector Is it the medicines? Is it the insurance scheme? Is it data error?
  • 10. TAXES Impact Of GST There are two things that have changed which are the manufacturing price of many raw materials for API and product moved from 5% vat Bracket to 12% GST bracket and a lot of medicines salts/compounds have moved from 5% to 12% GST bracket.
  • 11. MONETARY POLICY FISCAL POLICY • Monetary policy is the macroeconomic policy laid down by the central bank to achieve macroeconomic objectives like inflation consumption and growth. • Key monetary policy instruments are open market operations, CRR, SLR, Repo and reverse repo rate. • Fiscal policy is the macroeconomic policy which deals with the taxation and expenditure decisions of the government. • Some of the major instruments of fiscal policy are as follows: Budget, Taxation, Public Expenditure, public revenue, Public Debt, and Fiscal Deficit in the economy.
  • 13. • Intellectual property rights such as patents provide pharma companies exclusive rights to make drugs and prevent others to manufacture, sell, and make these drugs for A period of 20 years. • A progressive policies regarding the IPR have an positive impact on the pharmaceutical industry.
  • 14. RESEARCH & DEVELOPMENT/ INNOVATION  The R&D efficiencies of major research-based pharmaceutical companies were in the range of USD 3.2–32.3 billion (2006–2014). [Journal of Translation Medicine, 2016]  The total worldwide R&D spend of pharmaceutical and biotechnology companies increased from USD 108 billion (2006) to USD 141 billion (2015) whereas Top five Indian pharma companies together spent over Rs. 8000 crore on R&D spend in FY17. [Bloomberg]  Medicine spending in India is projected to grow 9-12 per cent over the next five years, leading India to become one of the top 10 countries in terms of medicine spending.
  • 15. EXCHANGE RATE  Rupee depreciation against the Dollar will result in cash inflows for pharmaceutical companies that derive a significant part of their revenues from the US.  Firms, which undertook forward contracts of hedging their sales revenues so as to insulate themselves from currency fluctuations, will not benefit much from Rupee depreciation.  Profitability of companies is also affected by loans they owe in foreign currency. Higher Dollar conversion rate invariably results in higher interest and loan repayments.